Xiamen Amoytop Biotech Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-11-18 | NCT07946757 Phase Ib Clinical Trial of ACT201 Injection in Participants With Treatment-Naïve Chronic… | Phase 1 | Not Yet Recruiting |
| 2026-11-10 | NCT07929805 ACT201 Injection in Participants With Chronic Hepatitis B (CHB) on Nucleos(t)Ide Analog… | Phase 1 | Not Yet Recruiting |
| 2026-10-26 | NCT07894341 A Clinical Study of Long-Term Administration of Inpegsomatropin Injection in Participants… | Recruiting |
Active trials by phase
| Phase 1 | 6 | |
| Phase 2 | 2 | |
| Phase 3 | 3 |
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
NASH / MASH (2) · Heart Disease (1) · Lupus (SLE) (1)
Get alerts when Xiamen Amoytop Biotech Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.